Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease

Journal of Immunology

Volumn 186, Issue 8, 2011, Pages 4734-4743

  Mao, Chaoming ^a,b   Wang, Shu ^c   Xiao, Yichuan ^a   Xu, Jingwei ^a   Jiang, Qian ^b   Jin, Min ^a   Jiang, Xiaohua ^c,d   Guo, Hua ^c,d   Ning, Guang ^c,d   Zhang, Yanyun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; PURINERGIC P2Y6 RECEPTOR; THYROID HORMONE; THYROTROPIN RECEPTOR ANTIBODY; TRANSCRIPTION FACTOR FOXP3; URIDINE DIPHOSPHATE;

ADULT; APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CD4+ CD25+ T LYMPHOCYTE; CELL INTERACTION; CELL LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GRAVES DISEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PLASMACYTOID DENDRITIC CELL; POLARIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ADULT; APOPTOSIS; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; HYPERTHYROIDISM; INTERFERON-ALPHA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MODELS, IMMUNOLOGICAL; RECEPTORS, PURINERGIC P2; RECEPTORS, THYROTROPIN; T-LYMPHOCYTES, REGULATORY; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 79954988832     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904135     Document Type: Article

References (58)

1. Rapoport, B., G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan. 1998. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr. Rev. 19:673-716. (Pubitemid 128506520)
2. Prabhakar, B. S., R. S. Bahn, and T. J. Smith. 2003. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr. Rev. 24:802-835. (Pubitemid 38067700)
3. Morgan, M. E., R. P. Sutmuller, H. J. Witteveen, L. M. van Duivenvoorde, E. Zanelli, C. J. Melief, A. Snijders, R. Offringa, R. R. de Vries, and R. E. Toes. 2003. CD25+ cell depletion hastens the onset of severe disease in collageninduced arthritis. Arthritis Rheum. 48:1452-1460. (Pubitemid 36554546)
4. Wang, S. H., G. H. Chen, Y. Fan, M. Van Antwerp, and J. R. Baker, Jr. 2009. Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Endocrinology 150:2000-2007.
5. Ban, Y., T. Tozaki, T. Tobe, Y. Ban, E. M. Jacobson, E. S. Concepcion, and Y. Tomer. 2007. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J. Autoimmun. 28:201-207. (Pubitemid 46805032)
6. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345-352. (Pubitemid 41716771)
7. Lim, H. W., P. Hillsamer, A. H. Banham, and C. H. Kim. 2005. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol. 175:4180-4183. (Pubitemid 41361949)
8. Iikuni, N., E. V. Lourenço, B. H. Hahn, and A. La Cava. 2009. Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus. J. Immunol. 183:1518-1522.
9. McHugh, R. S., and E. M. Shevach. 2002. Cutting edge: depletion of CD4+ CD25+ regulatory T cells is necessary, but not sufficient, for induction of organspecific autoimmune disease. J. Immunol. 168:5979-5983. (Pubitemid 34620008)
10. Morris, G. P., L. Chen, and Y. C. Kong. 2003. CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell. Immunol. 226:20-29. (Pubitemid 38121294)
11. Morris, G. P., N. K. Brown, and Y. C. Kong. 2009. Naturally-existing CD4 (+) CD25 (+) Foxp3 (+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J. Autoimmun. 33:68-76.
12. Viglietta, V., C. Baecher-Allan, H. L. Weiner, and D. A. Hafler. 2004. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:971-979. (Pubitemid 38481088)
13. Kohm, A. P., J. S. Williams, and S. D. Miller. 2004. Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. J. Immunol. 172:4686-4690. (Pubitemid 38456388)
14. Wu, A. J., H. Hua, S. H. Munson, and H. O. McDevitt. 2002. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99:12287-12292.
15. Mottet, C., H. H. Uhlig, and F. Powrie. 2003. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170:3939-3943. (Pubitemid 36428153)
16. Liu, H., B. Hu, D. Xu, and F. Y. Liew. 2003. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J. Immunol. 171:5012-5017. (Pubitemid 37432781)
17. Saitoh, O., and Y. Nagayama. 2006. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 147:2417-2422.
18. Saxena, V., J. K. Ondr, A. F. Magnusen, D. H. Munn, and J. D. Katz. 2007. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J. Immunol. 179:5041-5053.
19. Ouabed, A., F. X. Hubert, D. Chabannes, L. Gautreau, M. Heslan, and R. Josien. 2008. Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells. J. Immunol. 180:5862-5870.
20. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D. W. Buck, and J. Schmitz. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037-6046.
21. Piqueras, B., J. Connolly, H. Freitas, A. K. Palucka, and J. Banchereau. 2006. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107:2613-2618.
22. McKenna, K., A. S. Beignon, and N. Bhardwaj. 2005. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 79:17-27. (Pubitemid 39648359)
23. Adams, S., D. W. O'Neill, and N. Bhardwaj. 2005. Recent advances in dendritic cell biology. J. Clin. Immunol. 25:177-188.
24. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8:594-606.
25. Veckman, V., and I. Julkunen. 2008. Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells. J. Leukoc. Biol. 83:296-304. (Pubitemid 351225610)
26. Gangi, E., C. Vasu, D. Cheatem, and B. S. Prabhakar. 2005. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol. 174:7006-7013. (Pubitemid 40705665)
27. Fehérvári, Z., and S. Sakaguchi. 2004. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol. 16:1769-1780. (Pubitemid 40003865)
28. Verginis, P., H. S. Li, and G. Carayanniotis. 2005. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J. Immunol. 174:7433-7439. (Pubitemid 40705715)
29. Ahn, J. S., D. K. Krishnadas, and B. Agrawal. 2007. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Int. Immunol. 19:227-237. (Pubitemid 46344687)
30. Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G. D. Victora, T. Eisenreich, K. H. Yao, R. F. Masilamani, M. L. Dustin, A. Rudensky, K. Liu, and M. C. Nussenzweig. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206:1853-1862.
31. Liu, K., G. D. Victora, T. A. Schwickert, P. Guermonprez, M. M. Meredith, K. Yao, F. F. Chu, G. J. Randolph, A. Y. Rudensky, and M. Nussenzweig. 2009. In vivo analysis of dendritic cell development and homeostasis. Science 324:392-397.
32. Yan, B., S. Ye, G. Chen, M. Kuang, N. Shen, and S. Chen. 2008. Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum. 58:801-812. (Pubitemid 351364878)
33. Godoy-Ramirez, K., B. Mäkitalo, R. Thorstensson, E. Sandström, G. Biberfeld, and H. Gaines. 2005. A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry. Cytometry A 68:71-80. (Pubitemid 41705200)
34. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8:277-284. (Pubitemid 46745377)
35. Shin, A., T. Toy, S. Rothenfusser, N. Robson, J. Vorac, M. Dauer, M. Stuplich, S. Endres, J. Cebon, E. Maraskovsky, and M. Schnurr. 2008. P2Y receptor signaling regulates phenotype and IFN-alpha secretion of human plasmacytoid dendritic cells. Blood 111:3062-3069.
36. Idzko, M., H. Hammad, M. van Nimwegen, M. Kool, M. A. Willart, F. Muskens, H. C. Hoogsteden, W. Luttmann, D. Ferrari, F. Di Virgilio, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13:913-919. (Pubitemid 47222044)
37. Marazuela, M., M. A. García-López, N. Figueroa-Vega, H. de la Fuente, B. Alvarado-Sánchez, A. Monsiváis-Urenda, F. Sánchez-Madrid, and R. González-Amaro. 2006. Regulatory T cells in human autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 91:3639-3646. (Pubitemid 44402149)
38. Yates, J., A. Whittington, P. Mitchell, R. I. Lechler, L. Lightstone, and G. Lombardi. 2008. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin. Exp. Immunol. 153:44-55. (Pubitemid 351809334)
39. Nakano, A., M. Watanabe, T. Iida, S. Kuroda, F. Matsuzuka, A. Miyauchi, and Y. Iwatani. 2007. Apoptosis-induced decrease of intrathyroidal CD4 (+) CD25 (+) regulatory T cells in autoimmune thyroid diseases. Thyroid 17:25-31. (Pubitemid 46214719)
40. Pan, D., Y. H. Shin, G. Gopalakrishnan, J. Hennessey, and L. J. De Groot. 2009. Regulatory T cells in Graves' disease. Clin. Endocrinol. (Oxf.) 71:587-593.
41. Wang, H., S. Zhao, X. Tang, J. Li, and P. Zou. 2006. Changes ofregulatory Tcells in Graves' disease. J. Huazhong Univ. Sci. Technolog. Med. Sci. 26:545-547.
42. Alvarado-Sánchez, B., B. Hernández-Castro, D. Portales-Pérez, L. Baranda, E. Layseca-Espinosa, C. Abud-Mendoza, A. C. Cubillas-Tejeda, and R. González-Amaro. 2006. Regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 27:110-118. (Pubitemid 44528260)
43. Gottenberg, J. E., F. Lavie, K. Abbed, J. Gasnault, E. Le Nevot, J. F. Delfraissy, Y. Taoufik, and X. Mariette. 2005. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J. Autoimmun. 24:235-242. (Pubitemid 40545886)
44. Valencia, X., C. Yarboro, G. Illei, and P. E. Lipsky. 2007. Deficient CD4+ CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178:2579-2588. (Pubitemid 46233461)
45. Balandina, A., S. Lécart, P. Dartevelle, A. Saoudi, and S. Berrih-Aknin. 2005. Functional defect of regulatory CD4 (+) CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105:735-741. (Pubitemid 40070760)
46. Klecha, A. J., M. L. Barreiro Arcos, L. Frick, A. M. Genaro, and G. Cremaschi. 2008. Immune-endocrine interactions in autoimmune thyroid diseases. Neuroimmunomodulation 15:68-75.
47. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252. (Pubitemid 28155090)
48. Pascual, V., L. Farkas, and J. Banchereau. 2006. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 18:676-682. (Pubitemid 44635182)
49. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294:1540-1543. (Pubitemid 33063928)
50. Gupta, M. K., T. Chiang, and S. D. Deodhar. 1983. Effect of thyroxine on immune response in C57Bl/6J mice. Acta Endocrinol. (Copenh.) 103:76-80. (Pubitemid 13118727)
51. Papic, M., J. Stein-Streilein, M. Zakarija, J. M. McKenzie, J. Guffee, and M. A. Fletcher. 1987. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J. Clin. Invest. 79:404-408. (Pubitemid 17009672)
52. Ribeiro-Carvalho, M. M., S. Smaniotto, S. Neves-dos-Santos, T. Mouço, W. Savino, and V. Mello-Coelho. 2007. Triiodothyronine modulates differential homing of recent thymic emigrants to peripheral lymphoid organs. Scand. J. Immunol. 66:8-16. (Pubitemid 46985506)
53. Mascanfroni, I. D., Mdel. M. Montesinos, V. A. Alamino, S. Susperreguy, J. P. Nicola, J. M. Ilarregui, A. M. Masini-Repiso, G. A. Rabinovich, and C. G. Pellizas. 2010. Nuclear factor (NF)-kappaB-dependent thyroid hormone receptor beta1 expression controls dendritic cell function via Akt signaling. J. Biol. Chem. 285:9569-9582.
54. Mascanfroni, I., Mdel. M. Montesinos, S. Susperreguy, L. Cervi, J. M. Ilarregui, V. D. Ramseyer, A. M. Masini-Repiso, H. M. Targovnik, G. A. Rabinovich, and C. G. Pellizas. 2008. Control of dendritic cell maturation and function by triiodothyronine. FASEB J. 22:1032-1042. (Pubitemid 351519958)
55. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687-697.
56. Kwok, S. K., J. Y. Lee, S. H. Park, M. L. Cho, S. Y. Min, S. H. Park, H. Y. Kim, and Y. G. Cho. 2008. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Arthritis Res. Ther. 10: R29.
57. Dzionek, A., Y. Sohma, J. Nagafune, M. Cella, M. Colonna, F. Facchetti, G. Günther, I. Johnston, A. Lanzavecchia, T. Nagasaka, et al. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194:1823-1834. (Pubitemid 34028661)
58. Shodell, M., and F. P. Siegal. 2001. Corticosteroids depress IFN-alpha-producing plasmacytoid dendritic cells in human blood. J. Allergy Clin. Immunol. 108:446-448. (Pubitemid 32881068)